OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SGMO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Sangamo Therapeutics (SGMO) Earnings Date & Reports

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SGMO is expected to report earnings to fall 27.37% to -5 cents per share on October 30

Sangamo Therapeutics SGMO Stock Earnings Reports

Q3'25

Est.

$-0.06

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.05

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.06

The last earnings report on August 07 showed earnings per share of -7 cents, missing the estimate of -1 cents. With 1.60M shares outstanding, the current market capitalization sits at 112.12M.

View a ticker or compare two or three

Compare

SGMO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SGMO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SGMO showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

501 Canal Boulevard

Phone

+1 510 970-6000

Employees

405

Web

https://www.sangamo.com